Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2007-12-17
- Last Posted Date
- 2015-10-02
- Lead Sponsor
- Allergan
- Target Recruit Count
- 74
- Registration Number
- NCT00575016
A Study of 2 Doses of MAP0010 and Placebo in Asthmatic Children
- First Posted Date
- 2007-12-07
- Last Posted Date
- 2014-01-09
- Lead Sponsor
- Allergan
- Target Recruit Count
- 360
- Registration Number
- NCT00569192
Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-11-28
- Last Posted Date
- 2016-01-05
- Lead Sponsor
- Allergan
- Target Recruit Count
- 242
- Registration Number
- NCT00564681
A Study of 2 Doses of MAP0010 in Adult Asthmatics
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-11-07
- Last Posted Date
- 2014-01-09
- Lead Sponsor
- Allergan
- Target Recruit Count
- 32
- Registration Number
- NCT00554970
- Locations
- 🇺🇸
West Coast Clinical Trials Phase 2-4, LLC, Long Beach, California, United States
BOTOX® Economic Spasticity Trial (BEST)
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-10-26
- Last Posted Date
- 2012-08-22
- Lead Sponsor
- Allergan
- Target Recruit Count
- 274
- Registration Number
- NCT00549783
Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-10-16
- Last Posted Date
- 2011-12-14
- Lead Sponsor
- Allergan
- Target Recruit Count
- 228
- Registration Number
- NCT00544713
Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-10-10
- Last Posted Date
- 2011-10-27
- Lead Sponsor
- Allergan
- Target Recruit Count
- 586
- Registration Number
- NCT00541242
Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-10-04
- Last Posted Date
- 2019-04-24
- Lead Sponsor
- Allergan
- Target Recruit Count
- 106
- Registration Number
- NCT00539526
A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-10-02
- Last Posted Date
- 2019-04-23
- Lead Sponsor
- Allergan
- Target Recruit Count
- 222
- Registration Number
- NCT00538304
MDs on Botox Utility (MOBILITY)
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-09-27
- Last Posted Date
- 2014-09-10
- Lead Sponsor
- Allergan
- Target Recruit Count
- 1372
- Registration Number
- NCT00535938
© Copyright 2024. All Rights Reserved by MedPath